The MarketWatch News Department was not involved in the creation of this content. First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps -- ...
Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...
Cancer is most treatable in its early stages, so finding innovative and non-invasive methods to diagnose cancer early on is crucial for fighting the disease. Liquid biopsies, which require just a ...
Researchers developed a new RNA sequencing strategy that can reveal how genetic variants disrupt gene function and improve the diagnosis of rare diseases. The study team demonstrated that this ...
Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease Ambry Genetics first implemented RNA testing in 2016 as part of a research and ...
Morning Overview on MSN
Long-read RNA sequencing tool boosts rare-disease diagnoses missed by DNA tests
For years, two siblings with the distinctive facial features of Treacher Collins syndrome had no genetic explanation for ...
Study aims to enhance colorectal cancer prevention by identifying polyp molecular signals, offering improved sensitivity over at-home DNA tests, which have limited ability to detect precancerous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results